Candidat au poste de Directeur général de l’OMS
Publications
Explorez les publications sur la santé publique, les systèmes de santé et la coopération internationale. Recherchez dans la collection complète ou parcourez les pages.
Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, D'Ambrosio L, Centis R, Sotgiu G, Menegale O, Kliiman K, Aksamit T, Cirillo DM, Danilovits M, Dara M, Dheda K, Dinh-Xuan AT, Kluge H , Lange C, Leimane V, Loddenkemper R, Nicod LP, Raviglione MC, Spanevello A, Thomsen VØ, Villar M, Wanlin M, Wedzicha JA, Zumla A, Blasi F, Huitric E, Sandgren A, Manissero D. European union standards for tuberculosis care . Eur Respir J. 2012 Apr;39(4):807-19.
Jakab Z, Acosta CD, Kluge HH , Dara M. Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011-2015: Cost-effectiveness analysis. Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S212-6. .
Lönnroth K, Aung T, Maung W, Kluge H , Uplekar M. Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection. Health Policy Plan. 2007 May;22(3):156-66.
Maung M, Kluge H , Aye T, Maung W, Noe P, Zaw M, Jost SP, Uplekar M, Lönnroth K. Private GPs contribute to TB control in Myanmar: evaluation of a PPM initiative in Mandalay Division. Int J Tuberc Lung Dis. 2006 Sep;10(9):982-7.
Kimerling ME, Kluge H . The need for longitudinal screening studies in prison TB control . Int J Tuberc Lung Dis. 2005 Jun;9(6):589.
Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H , Jakubowiak W, Wells C, Kazionny B. Risk factors for death during tuberculosis treatment in Orel, Russia . Int J Tuberc Lung Dis. 2004 May;8(5):598-602. PMID: 15137537.
Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H , Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. Int J Tuberc Lung Dis. 2003 Nov;7(11):1045-51.
Ti T, Lwin T, Mar TT, Maung W, Noe P, Htun A, Kluge HH , Wright A, Aziz MA, Paramasivan CN. National anti-tuberculosis drug resistance survey, 2002, in Myanmar. Int J Tuberc Lung Dis. 2006 Oct;10(10):1111-6.
Spradling P, Nemtsova E, Aptekar T, Shulgina M, Rybka L, Wells C, Aquino G, Kluge H , Jakubowiak W, Binkin N, Kazeonny B. Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis. 2002 Sep;6(9):757-62.
Kluge HHP, Azzopardi Muscat N, Lazëri L. Mental health in the European region since the WHO 2001 report. Lancet Psychiatry. 2023 Nov;10(11):828-829.
Kazionny B, Wells CD, Kluge H , Gusseynova N, Molotilov V. Implications of the growing HIV-1 epidemic for tuberculosis control in Russia. Lancet. 2001 Nov 3;358(9292):1513-4.
Kimerling ME, Kluge H , Vezhnina N, Iacovazzi T, Demeulenaere T, Portaels F, Matthys F. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis. 1999 May;3(5):451-3.
Aucune publication ne correspond à ces filtres.
Les références sont reproduites dans leur langue d’origine. Les titres ne sont pas traduits.